Free Trial

PyroGenesis Canada (PYRGF) Competitors

PyroGenesis Canada logo
$0.34 +0.01 (+2.37%)
As of 07/3/2025 12:24 PM Eastern

PYRGF vs. DBVT, CADL, NGNE, SLRN, IMMP, ACB, DSGN, CGC, CMPS, and YMAB

Should you be buying PyroGenesis Canada stock or one of its competitors? The main competitors of PyroGenesis Canada include DBV Technologies (DBVT), Candel Therapeutics (CADL), Neurogene (NGNE), Acelyrin (SLRN), Prima BioMed (IMMP), Aurora Cannabis (ACB), Design Therapeutics (DSGN), Canopy Growth (CGC), COMPASS Pathways (CMPS), and Y-mAbs Therapeutics (YMAB). These companies are all part of the "pharmaceutical products" industry.

PyroGenesis Canada vs. Its Competitors

DBV Technologies (NASDAQ:DBVT) and PyroGenesis Canada (NASDAQ:PYRGF) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, media sentiment and dividends.

In the previous week, DBV Technologies had 4 more articles in the media than PyroGenesis Canada. MarketBeat recorded 7 mentions for DBV Technologies and 3 mentions for PyroGenesis Canada. DBV Technologies' average media sentiment score of 0.89 beat PyroGenesis Canada's score of 0.00 indicating that DBV Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DBV Technologies
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PyroGenesis Canada
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

71.7% of DBV Technologies shares are held by institutional investors. Comparatively, 0.0% of PyroGenesis Canada shares are held by institutional investors. 1.4% of DBV Technologies shares are held by insiders. Comparatively, 47.7% of PyroGenesis Canada shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

DBV Technologies has a beta of -0.59, suggesting that its stock price is 159% less volatile than the S&P 500. Comparatively, PyroGenesis Canada has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500.

PyroGenesis Canada has a net margin of -115.14% compared to DBV Technologies' net margin of -3,249.99%. PyroGenesis Canada's return on equity of 0.00% beat DBV Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
DBV Technologies-3,249.99% -278.24% -140.54%
PyroGenesis Canada -115.14%N/A -60.81%

PyroGenesis Canada has higher revenue and earnings than DBV Technologies. PyroGenesis Canada is trading at a lower price-to-earnings ratio than DBV Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DBV Technologies$4.15M76.16-$113.92M-$4.92-2.35
PyroGenesis Canada$9.14M6.96-$21.12M-$0.02-17.05

DBV Technologies currently has a consensus price target of $14.75, indicating a potential upside of 27.83%. Given DBV Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe DBV Technologies is more favorable than PyroGenesis Canada.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DBV Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.80
PyroGenesis Canada
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

DBV Technologies beats PyroGenesis Canada on 9 of the 17 factors compared between the two stocks.

Get PyroGenesis Canada News Delivered to You Automatically

Sign up to receive the latest news and ratings for PYRGF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PYRGF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PYRGF vs. The Competition

MetricPyroGenesis CanadaPharmaceutical IndustryIndustrials SectorNASDAQ Exchange
Market Cap$63.64M$813.43M$7.53B$8.95B
Dividend YieldN/A4.84%4.55%4.09%
P/E Ratio-5.681.1024.9720.24
Price / Sales6.96220.40116.26125.07
Price / CashN/A23.4427.3557.47
Price / Book-34.096.104.365.67
Net Income-$21.12M-$27.81M$791.63M$248.47M
7 Day Performance4.09%0.76%2.40%3.29%
1 Month Performance-12.00%8.10%5.71%5.18%
1 Year Performance-36.87%7.76%32.73%21.35%

PyroGenesis Canada Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PYRGF
PyroGenesis Canada
0.096 of 5 stars
$0.34
+2.4%
N/A-36.9%$63.64M$9.14M-5.6890
DBVT
DBV Technologies
3.9024 of 5 stars
$8.73
+1.9%
$14.75
+69.1%
+203.7%$243.77M$4.15M-1.8180Gap Up
CADL
Candel Therapeutics
2.4921 of 5 stars
$4.83
+3.4%
$21.00
+334.9%
-19.2%$242.03M$120K-3.6160Analyst Revision
NGNE
Neurogene
3.8216 of 5 stars
$16.93
-1.7%
$46.17
+172.8%
-44.3%$241.35M$930K-3.8990
SLRN
Acelyrin
N/A$2.27
flat
$9.60
+322.9%
N/A$229.17MN/A-0.92135
IMMP
Prima BioMed
0.9261 of 5 stars
$1.55
+1.6%
$7.00
+353.1%
-13.6%$225.63M$5.14M0.002,021
ACB
Aurora Cannabis
0.2092 of 5 stars
$4.02
+2.7%
N/A-6.6%$225.12M$246.72M36.411,073
DSGN
Design Therapeutics
0.4025 of 5 stars
$3.97
+1.7%
$4.00
+0.9%
+18.2%$224.81MN/A-4.0040
CGC
Canopy Growth
2.8295 of 5 stars
$1.23
+2.9%
$2.00
+63.3%
-80.0%$223.40M$225.65M-0.303,150
CMPS
COMPASS Pathways
1.6694 of 5 stars
$2.37
+0.6%
$17.00
+618.8%
-48.0%$221.27MN/A-1.19120Gap Down
High Trading Volume
YMAB
Y-mAbs Therapeutics
2.602 of 5 stars
$4.87
+3.1%
$15.60
+220.7%
-62.2%$220.65M$87.68M-7.61150News Coverage

Related Companies and Tools


This page (NASDAQ:PYRGF) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners